Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
preclinical studies
Research
‘Low tech’ chemotherapy nanoparticles treated deadly brain tumor
A standard chemo drug loaded in nanoparticles was able to penetrate the blood-brain barrier when administered shortly after resection of the tumor
Marissa Russo
Jul 29, 2026 2:30pm
Valneva closes site to consolidate R&D footprint, lays off 30
Nov 26, 2025 12:57pm
Psychiatrist launches new CRO with patient-centered focus
Oct 22, 2025 2:22pm
FDA delays hit clinical trial launch decisions
Jul 30, 2025 10:29am
Korean CRO inks collab to expand into organoids, transcriptomics
Jul 22, 2025 3:10pm
Investigational MS drug restores mobility in mice
Jan 2, 2025 2:15pm
